UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ENDOCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
33-0618093 |
|
|
|
(State of incorporation or organization)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
201 Technology Drive, Irvine, California
|
|
92618 |
|
(Address of principal executive offices)
|
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered |
|
|
|
Common Stock, $0.001 par value per share
|
|
The NASDAQ Stock Market LLC |
|
|
|
|
|
|
Preferred Stock Purchase Rights
|
|
The NASDAQ Stock Market LLC |
|
|
|
If this form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the
following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of
the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.
o
Securities Act registration statement file number to which this form relates:
____________________(if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
NONE
Title of Class
TABLE OF CONTENTS
Item 1. Description of Registrants Securities to Be Registered.
A description of the common stock, par value $0.001 per share, of Endocare, Inc., a Delaware
corporation (the Registrant), that is registered hereunder is provided under the caption
Description of Capital Stock in the Registrants Form 10-SB initially filed with the Securities
and Exchange Commission (the Commission) on November 14, 1995 (the Form 10-SB). A description
of the preferred stock purchase rights of the Registrant that is registered hereunder is provided
under the caption Description of Registrants Securities to Be Registered in the Registrants
Form 8-A filed with the Commission on June 28, 2005 (the Form 8-A). Such portions of the Form
10-SB and Form 8-A are incorporated herein by reference.
Item 2. Exhibits.
Pursuant to the Instructions as to Exhibits in Form 8-A, no exhibits are filed herein.
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the
Registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
|
Endocare, Inc.
|
|
Date: October 9, 2007 |
By: |
/s/ Michael R. Rodriguez
|
|
|
|
Michael R. Rodriguez |
|
|
|
Senior Vice President, Finance and Chief Financial
Officer |
|
|
3